J&J has announced the US FDA approval for the combination of Tecvayli and Darzalex Faspro for adults with RRMM.

This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set ...

The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term ...

Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a ...

Affinia Therapeutics has received the US FDA fast track designation for AFTX-201, a genetic medicine under investigation for ...

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with ...

Alnylam pens this cardiovascular deal with Tenaya as it looks to replicate the sales of its blockbuster ATTR-CM therapy, Amvuttra.

Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.

Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to CAR designs tailored for myeloid cells, such as monocytes and macrophages.

While some chief executives have left for personal reasons, others have been ousted amid poor company performance.

BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...